Current therapeutic market position of Ondansetron


Ondansetron is under the therapeutic class of Anti-emetic drugs. The main line of drugs of this therapeutics includes; Ondansetron, Prochlorperazine Maleate, Palonosetron, Meclizine Hydrochloride + Pyridoxine Hydrochloride, Chlorpromazine Hydrochloride, Doxylamine + Pyridoxine, Promethazine Hydrochloride, Metoclopramide Hydrochloride, Prochlorperazine Mesilate, Meclizine Hydrochloride, Hyoscine Hydro Bromide, Aprepitant, Promethazine Theoclate, Granisetron, Isopropamide + Trifluoperazine and Doxylamine Succinate. In recent year 2019, Ondansetron remained in first place for market size of Anti-emetic drugs. This generic meets 29.9% demands of an ever-changing market of Anti-emetic drugs. The other Anti-emetic drugs meet market demand 14.2% for Prochlorperazine Maleate, 13% for Palonosetron, 9.1% for Meclizine Hydrochloride + Pyridoxine Hydrochloride, 8% for Chlorpromazine Hydrochloride, 4.6% for Promethazine Hydrochloride, 4.2% for Metoclopramide Hydrochloride, 3.7% for Doxylamine + Pyridoxine, 3.5% for Prochlorperazine Mesilate, 3.4% for Meclizine Hydrochloride, 1.5% for Granisetron, 1.5% for Hyoscine Hydro Bromide, 1.4% for Aprepitant, 1.4% for Promethazine Theoclate, 0.5% for Isopropamide + Trifluoperazine and 0.1% for Doxylamine Succinate.

You might be interested to our other reports 

Get Registered for more detail